GlassScriptPhysician profile
Katherine E Mccuaig
NPI 1467484659
$926.71
in general payments reported to CMS, 2019-2025
8 companies · $319 in 2025
The $319 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.22 · 2023: $94.05 · 2024: $441 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $854.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $854.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $559.56 | 2019-2025 | Collagenase Santyl, Grafix Pl, Renasys Touch |
| Mimedx Group, INC. | $113.55 | 2024-2025 | |
| Urgo Medical North America, LLC | $91.63 | 2023-2025 | Urgok2, Urgoclean Ag |
| Hydrofera LLC | $79.67 | 2024-2025 | Hydrofera Blue |
| Advanced Oxygen Therapy INC. | $24.19 | 2023-2024 | Topical Oxygen Chamber For Extremities, Topical Oxygen Chamber For Extremities |
| Ovik Health, LLC | $20.73 | 2019 | |
| Integra Lifesciences Corporation | $20.48 | 2024 | Tcc-Ez |
| Boston Scientific Corporation | $16.90 | 2023 | Solyx Sis System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Mccuaig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.